nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—Cytochrome P450 2D6 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.509	1	CiPCiCtD
Mirabegron—ALB—acquired immunodeficiency syndrome	0.128	1	CbGaD
Mirabegron—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0253	0.0895	CbGbCtD
Mirabegron—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0235	0.083	CbGbCtD
Mirabegron—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0228	0.0806	CbGbCtD
Mirabegron—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0206	0.0729	CbGbCtD
Mirabegron—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0206	0.0729	CbGbCtD
Mirabegron—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0107	0.0376	CbGbCtD
Mirabegron—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0102	0.0361	CbGbCtD
Mirabegron—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00815	0.0288	CbGbCtD
Mirabegron—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00813	0.0287	CbGbCtD
Mirabegron—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00766	0.0271	CbGbCtD
Mirabegron—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00766	0.0271	CbGbCtD
Mirabegron—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00735	0.026	CbGbCtD
Mirabegron—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00693	0.0245	CbGbCtD
Mirabegron—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00693	0.0245	CbGbCtD
Mirabegron—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00635	0.0224	CbGbCtD
Mirabegron—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00616	0.0218	CbGbCtD
Mirabegron—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00598	0.0211	CbGbCtD
Mirabegron—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00581	0.0205	CbGbCtD
Mirabegron—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00557	0.0197	CbGbCtD
Mirabegron—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00557	0.0197	CbGbCtD
Mirabegron—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00534	0.0189	CbGbCtD
Mirabegron—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00525	0.0186	CbGbCtD
Mirabegron—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00525	0.0186	CbGbCtD
Mirabegron—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00518	0.0183	CbGbCtD
Mirabegron—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00487	0.0172	CbGbCtD
Mirabegron—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00487	0.0172	CbGbCtD
Mirabegron—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00441	0.0156	CbGbCtD
Mirabegron—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00441	0.0156	CbGbCtD
Mirabegron—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00413	0.0146	CbGbCtD
Mirabegron—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0038	0.0134	CbGbCtD
Mirabegron—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00369	0.013	CbGbCtD
Mirabegron—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00334	0.0118	CbGbCtD
Mirabegron—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00334	0.0118	CbGbCtD
Mirabegron—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0032	0.0113	CbGbCtD
Mirabegron—ORM1—saliva—acquired immunodeficiency syndrome	0.00175	0.178	CbGeAlD
Mirabegron—BCHE—blood plasma—acquired immunodeficiency syndrome	0.000472	0.0479	CbGeAlD
Mirabegron—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000318	0.0323	CbGeAlD
Mirabegron—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000313	0.0318	CbGeAlD
Mirabegron—ORM1—blood—acquired immunodeficiency syndrome	0.000279	0.0283	CbGeAlD
Mirabegron—ORM1—bone marrow—acquired immunodeficiency syndrome	0.00027	0.0274	CbGeAlD
Mirabegron—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000269	0.0273	CbGeAlD
Mirabegron—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000258	0.0262	CbGeAlD
Mirabegron—ORM1—lung—acquired immunodeficiency syndrome	0.000245	0.0248	CbGeAlD
Mirabegron—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000237	0.0241	CbGeAlD
Mirabegron—BCHE—skin of body—acquired immunodeficiency syndrome	0.000227	0.023	CbGeAlD
Mirabegron—ORM1—nervous system—acquired immunodeficiency syndrome	0.000227	0.023	CbGeAlD
Mirabegron—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000225	0.0228	CbGeAlD
Mirabegron—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000218	0.0221	CbGeAlD
Mirabegron—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000216	0.0219	CbGeAlD
Mirabegron—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.0002	0.0203	CbGeAlD
Mirabegron—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000192	0.0195	CbGeAlD
Mirabegron—BCHE—digestive system—acquired immunodeficiency syndrome	0.000182	0.0184	CbGeAlD
Mirabegron—BCHE—blood—acquired immunodeficiency syndrome	0.000173	0.0176	CbGeAlD
Mirabegron—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000167	0.017	CbGeAlD
Mirabegron—ORM1—lymph node—acquired immunodeficiency syndrome	0.000167	0.017	CbGeAlD
Mirabegron—BCHE—spinal cord—acquired immunodeficiency syndrome	0.000167	0.0169	CbGeAlD
Mirabegron—BCHE—vagina—acquired immunodeficiency syndrome	0.00016	0.0163	CbGeAlD
Mirabegron—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000153	0.0155	CbGeAlD
Mirabegron—ALB—brain—acquired immunodeficiency syndrome	0.000152	0.0154	CbGeAlD
Mirabegron—BCHE—lung—acquired immunodeficiency syndrome	0.000152	0.0154	CbGeAlD
Mirabegron—ALB—lymph node—acquired immunodeficiency syndrome	0.000147	0.0149	CbGeAlD
Mirabegron—BCHE—nervous system—acquired immunodeficiency syndrome	0.00014	0.0143	CbGeAlD
Mirabegron—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000135	0.0137	CbGeAlD
Mirabegron—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000134	0.00191	CcSEcCtD
Mirabegron—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00191	CcSEcCtD
Mirabegron—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.0019	CcSEcCtD
Mirabegron—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000133	0.00189	CcSEcCtD
Mirabegron—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00189	CcSEcCtD
Mirabegron—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00186	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.00185	CcSEcCtD
Mirabegron—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00185	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00013	0.00185	CcSEcCtD
Mirabegron—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00013	0.00185	CcSEcCtD
Mirabegron—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.00184	CcSEcCtD
Mirabegron—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000129	0.00184	CcSEcCtD
Mirabegron—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00184	CcSEcCtD
Mirabegron—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00183	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.00183	CcSEcCtD
Mirabegron—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00182	CcSEcCtD
Mirabegron—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00182	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000128	0.00182	CcSEcCtD
Mirabegron—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00182	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.00181	CcSEcCtD
Mirabegron—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000127	0.00181	CcSEcCtD
Mirabegron—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.00181	CcSEcCtD
Mirabegron—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.0018	CcSEcCtD
Mirabegron—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.00179	CcSEcCtD
Mirabegron—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00179	CcSEcCtD
Mirabegron—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00179	CcSEcCtD
Mirabegron—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000125	0.00179	CcSEcCtD
Mirabegron—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00178	CcSEcCtD
Mirabegron—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000125	0.00178	CcSEcCtD
Mirabegron—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.00176	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.00176	CcSEcCtD
Mirabegron—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.00176	CcSEcCtD
Mirabegron—ABCB1—retina—acquired immunodeficiency syndrome	0.000123	0.0125	CbGeAlD
Mirabegron—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000123	0.00175	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000123	0.00175	CcSEcCtD
Mirabegron—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000123	0.00175	CcSEcCtD
Mirabegron—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00174	CcSEcCtD
Mirabegron—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000122	0.0124	CbGeAlD
Mirabegron—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.00174	CcSEcCtD
Mirabegron—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000122	0.00173	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000121	0.00173	CcSEcCtD
Mirabegron—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00172	CcSEcCtD
Mirabegron—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000121	0.00172	CcSEcCtD
Mirabegron—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.00172	CcSEcCtD
Mirabegron—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.00012	0.0122	CbGeAlD
Mirabegron—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00171	CcSEcCtD
Mirabegron—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.00171	CcSEcCtD
Mirabegron—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00012	0.00171	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000119	0.0017	CcSEcCtD
Mirabegron—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.00168	CcSEcCtD
Mirabegron—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000118	0.00168	CcSEcCtD
Mirabegron—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00168	CcSEcCtD
Mirabegron—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00167	CcSEcCtD
Mirabegron—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000117	0.00167	CcSEcCtD
Mirabegron—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.00166	CcSEcCtD
Mirabegron—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000117	0.00166	CcSEcCtD
Mirabegron—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000117	0.00166	CcSEcCtD
Mirabegron—CYP3A4—blood—acquired immunodeficiency syndrome	0.000116	0.0118	CbGeAlD
Mirabegron—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000116	0.00165	CcSEcCtD
Mirabegron—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.00164	CcSEcCtD
Mirabegron—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000115	0.00163	CcSEcCtD
Mirabegron—CYP2D6—blood—acquired immunodeficiency syndrome	0.000115	0.0116	CbGeAlD
Mirabegron—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00162	CcSEcCtD
Mirabegron—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.00162	CcSEcCtD
Mirabegron—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.00162	CcSEcCtD
Mirabegron—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000114	0.00162	CcSEcCtD
Mirabegron—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00161	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.0016	CcSEcCtD
Mirabegron—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000113	0.0016	CcSEcCtD
Mirabegron—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000112	0.0016	CcSEcCtD
Mirabegron—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00159	CcSEcCtD
Mirabegron—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000112	0.00159	CcSEcCtD
Mirabegron—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00158	CcSEcCtD
Mirabegron—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.00158	CcSEcCtD
Mirabegron—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000111	0.00158	CcSEcCtD
Mirabegron—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00157	CcSEcCtD
Mirabegron—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00156	CcSEcCtD
Mirabegron—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.00155	CcSEcCtD
Mirabegron—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.00155	CcSEcCtD
Mirabegron—BCHE—brain—acquired immunodeficiency syndrome	0.000107	0.0109	CbGeAlD
Mirabegron—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000107	0.00152	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.00152	CcSEcCtD
Mirabegron—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.00152	CcSEcCtD
Mirabegron—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00151	CcSEcCtD
Mirabegron—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.00151	CcSEcCtD
Mirabegron—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.00151	CcSEcCtD
Mirabegron—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.00151	CcSEcCtD
Mirabegron—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.0015	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000105	0.00149	CcSEcCtD
Mirabegron—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.00149	CcSEcCtD
Mirabegron—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000104	0.00149	CcSEcCtD
Mirabegron—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.00148	CcSEcCtD
Mirabegron—BCHE—lymph node—acquired immunodeficiency syndrome	0.000104	0.0105	CbGeAlD
Mirabegron—Rash—Didanosine—acquired immunodeficiency syndrome	0.000103	0.00147	CcSEcCtD
Mirabegron—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.00147	CcSEcCtD
Mirabegron—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000103	0.00147	CcSEcCtD
Mirabegron—Headache—Didanosine—acquired immunodeficiency syndrome	0.000103	0.00146	CcSEcCtD
Mirabegron—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.00146	CcSEcCtD
Mirabegron—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000102	0.00146	CcSEcCtD
Mirabegron—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.00145	CcSEcCtD
Mirabegron—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00145	CcSEcCtD
Mirabegron—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000101	0.00144	CcSEcCtD
Mirabegron—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000101	0.00143	CcSEcCtD
Mirabegron—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00143	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.00142	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.95e-05	0.00142	CcSEcCtD
Mirabegron—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.93e-05	0.00141	CcSEcCtD
Mirabegron—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.93e-05	0.00141	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.92e-05	0.00141	CcSEcCtD
Mirabegron—Constipation—Indinavir—acquired immunodeficiency syndrome	9.85e-05	0.0014	CcSEcCtD
Mirabegron—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.84e-05	0.0014	CcSEcCtD
Mirabegron—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.0014	CcSEcCtD
Mirabegron—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.81e-05	0.0014	CcSEcCtD
Mirabegron—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.79e-05	0.00139	CcSEcCtD
Mirabegron—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.78e-05	0.00139	CcSEcCtD
Mirabegron—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.75e-05	0.00139	CcSEcCtD
Mirabegron—Nausea—Didanosine—acquired immunodeficiency syndrome	9.75e-05	0.00139	CcSEcCtD
Mirabegron—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.00138	CcSEcCtD
Mirabegron—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.61e-05	0.00137	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.6e-05	0.00137	CcSEcCtD
Mirabegron—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.58e-05	0.00136	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.49e-05	0.00135	CcSEcCtD
Mirabegron—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.46e-05	0.0096	CbGeAlD
Mirabegron—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.00135	CcSEcCtD
Mirabegron—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.45e-05	0.00135	CcSEcCtD
Mirabegron—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.42e-05	0.00134	CcSEcCtD
Mirabegron—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.42e-05	0.00134	CcSEcCtD
Mirabegron—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.00134	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.4e-05	0.00134	CcSEcCtD
Mirabegron—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.38e-05	0.00134	CcSEcCtD
Mirabegron—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.35e-05	0.00133	CcSEcCtD
Mirabegron—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.31e-05	0.00132	CcSEcCtD
Mirabegron—Rash—Nevirapine—acquired immunodeficiency syndrome	9.31e-05	0.00132	CcSEcCtD
Mirabegron—CYP2D6—nervous system—acquired immunodeficiency syndrome	9.31e-05	0.00944	CbGeAlD
Mirabegron—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.3e-05	0.00132	CcSEcCtD
Mirabegron—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.28e-05	0.00132	CcSEcCtD
Mirabegron—Headache—Nevirapine—acquired immunodeficiency syndrome	9.25e-05	0.00132	CcSEcCtD
Mirabegron—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.00131	CcSEcCtD
Mirabegron—Infection—Saquinavir—acquired immunodeficiency syndrome	9.21e-05	0.00131	CcSEcCtD
Mirabegron—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.17e-05	0.0013	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.16e-05	0.0013	CcSEcCtD
Mirabegron—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.15e-05	0.0013	CcSEcCtD
Mirabegron—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.11e-05	0.0013	CcSEcCtD
Mirabegron—CYP3A4—central nervous system—acquired immunodeficiency syndrome	9.1e-05	0.00924	CbGeAlD
Mirabegron—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.00128	CcSEcCtD
Mirabegron—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.01e-05	0.00128	CcSEcCtD
Mirabegron—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9e-05	0.00128	CcSEcCtD
Mirabegron—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9e-05	0.00128	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.00128	CcSEcCtD
Mirabegron—Rash—Stavudine—acquired immunodeficiency syndrome	8.99e-05	0.00128	CcSEcCtD
Mirabegron—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.98e-05	0.00128	CcSEcCtD
Mirabegron—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.98e-05	0.00128	CcSEcCtD
Mirabegron—CYP2D6—central nervous system—acquired immunodeficiency syndrome	8.96e-05	0.00909	CbGeAlD
Mirabegron—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.96e-05	0.00127	CcSEcCtD
Mirabegron—Headache—Stavudine—acquired immunodeficiency syndrome	8.93e-05	0.00127	CcSEcCtD
Mirabegron—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.91e-05	0.00127	CcSEcCtD
Mirabegron—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.9e-05	0.00127	CcSEcCtD
Mirabegron—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.89e-05	0.00126	CcSEcCtD
Mirabegron—Rash—Abacavir—acquired immunodeficiency syndrome	8.85e-05	0.00126	CcSEcCtD
Mirabegron—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.84e-05	0.00126	CcSEcCtD
Mirabegron—Headache—Abacavir—acquired immunodeficiency syndrome	8.79e-05	0.00125	CcSEcCtD
Mirabegron—Infection—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.00125	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.77e-05	0.00125	CcSEcCtD
Mirabegron—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.77e-05	0.00125	CcSEcCtD
Mirabegron—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.76e-05	0.00125	CcSEcCtD
Mirabegron—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.76e-05	0.00889	CbGeAlD
Mirabegron—ABCB1—digestive system—acquired immunodeficiency syndrome	8.65e-05	0.00878	CbGeAlD
Mirabegron—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.65e-05	0.00123	CcSEcCtD
Mirabegron—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.6e-05	0.00122	CcSEcCtD
Mirabegron—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.00122	CcSEcCtD
Mirabegron—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.00121	CcSEcCtD
Mirabegron—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.49e-05	0.00121	CcSEcCtD
Mirabegron—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.48e-05	0.00121	CcSEcCtD
Mirabegron—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.47e-05	0.00121	CcSEcCtD
Mirabegron—Nausea—Stavudine—acquired immunodeficiency syndrome	8.46e-05	0.0012	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.44e-05	0.0012	CcSEcCtD
Mirabegron—Nausea—Abacavir—acquired immunodeficiency syndrome	8.34e-05	0.00119	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.00118	CcSEcCtD
Mirabegron—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.3e-05	0.00118	CcSEcCtD
Mirabegron—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.27e-05	0.00118	CcSEcCtD
Mirabegron—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.26e-05	0.00118	CcSEcCtD
Mirabegron—ABCB1—blood—acquired immunodeficiency syndrome	8.25e-05	0.00837	CbGeAlD
Mirabegron—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.23e-05	0.00117	CcSEcCtD
Mirabegron—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.23e-05	0.00117	CcSEcCtD
Mirabegron—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.19e-05	0.00117	CcSEcCtD
Mirabegron—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.16e-05	0.00116	CcSEcCtD
Mirabegron—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.15e-05	0.00116	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.06e-05	0.00115	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.00114	CcSEcCtD
Mirabegron—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.99e-05	0.00114	CcSEcCtD
Mirabegron—ABCB1—bone marrow—acquired immunodeficiency syndrome	7.98e-05	0.0081	CbGeAlD
Mirabegron—ABCB1—spinal cord—acquired immunodeficiency syndrome	7.94e-05	0.00806	CbGeAlD
Mirabegron—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.93e-05	0.00113	CcSEcCtD
Mirabegron—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.88e-05	0.00112	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.00112	CcSEcCtD
Mirabegron—Rash—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.00111	CcSEcCtD
Mirabegron—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.81e-05	0.00111	CcSEcCtD
Mirabegron—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.8e-05	0.00111	CcSEcCtD
Mirabegron—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.78e-05	0.00111	CcSEcCtD
Mirabegron—Headache—Zidovudine—acquired immunodeficiency syndrome	7.76e-05	0.0011	CcSEcCtD
Mirabegron—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.7e-05	0.0011	CcSEcCtD
Mirabegron—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.65e-05	0.00109	CcSEcCtD
Mirabegron—ABCB1—vagina—acquired immunodeficiency syndrome	7.64e-05	0.00776	CbGeAlD
Mirabegron—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.00109	CcSEcCtD
Mirabegron—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.62e-05	0.00109	CcSEcCtD
Mirabegron—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.62e-05	0.00108	CcSEcCtD
Mirabegron—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.61e-05	0.00108	CcSEcCtD
Mirabegron—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.00108	CcSEcCtD
Mirabegron—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.56e-05	0.00108	CcSEcCtD
Mirabegron—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.47e-05	0.00106	CcSEcCtD
Mirabegron—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.00106	CcSEcCtD
Mirabegron—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.37e-05	0.00105	CcSEcCtD
Mirabegron—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.36e-05	0.00105	CcSEcCtD
Mirabegron—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.36e-05	0.00105	CcSEcCtD
Mirabegron—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.00104	CcSEcCtD
Mirabegron—Rash—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.00103	CcSEcCtD
Mirabegron—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.00103	CcSEcCtD
Mirabegron—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.00103	CcSEcCtD
Mirabegron—ABCB1—lung—acquired immunodeficiency syndrome	7.23e-05	0.00733	CbGeAlD
Mirabegron—Headache—Indinavir—acquired immunodeficiency syndrome	7.22e-05	0.00103	CcSEcCtD
Mirabegron—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.2e-05	0.00102	CcSEcCtD
Mirabegron—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.13e-05	0.00101	CcSEcCtD
Mirabegron—CYP2D6—brain—acquired immunodeficiency syndrome	7.11e-05	0.00722	CbGeAlD
Mirabegron—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.001	CcSEcCtD
Mirabegron—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.99e-05	0.000995	CcSEcCtD
Mirabegron—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.91e-05	0.000983	CcSEcCtD
Mirabegron—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.89e-05	0.00098	CcSEcCtD
Mirabegron—Rash—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000977	CcSEcCtD
Mirabegron—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000976	CcSEcCtD
Mirabegron—Nausea—Indinavir—acquired immunodeficiency syndrome	6.84e-05	0.000974	CcSEcCtD
Mirabegron—Headache—Efavirenz—acquired immunodeficiency syndrome	6.82e-05	0.000971	CcSEcCtD
Mirabegron—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.81e-05	0.00097	CcSEcCtD
Mirabegron—ABCB1—nervous system—acquired immunodeficiency syndrome	6.69e-05	0.00679	CbGeAlD
Mirabegron—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.65e-05	0.000947	CcSEcCtD
Mirabegron—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000938	CcSEcCtD
Mirabegron—Rash—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.000935	CcSEcCtD
Mirabegron—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.000934	CcSEcCtD
Mirabegron—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.56e-05	0.000933	CcSEcCtD
Mirabegron—Headache—Delavirdine—acquired immunodeficiency syndrome	6.52e-05	0.000929	CcSEcCtD
Mirabegron—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.46e-05	0.00092	CcSEcCtD
Mirabegron—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.44e-05	0.00654	CbGeAlD
Mirabegron—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.000906	CcSEcCtD
Mirabegron—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.34e-05	0.000903	CcSEcCtD
Mirabegron—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.34e-05	0.000903	CcSEcCtD
Mirabegron—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.26e-05	0.00089	CcSEcCtD
Mirabegron—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.19e-05	0.00088	CcSEcCtD
Mirabegron—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000872	CcSEcCtD
Mirabegron—Rash—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000864	CcSEcCtD
Mirabegron—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000863	CcSEcCtD
Mirabegron—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000861	CcSEcCtD
Mirabegron—Headache—Ritonavir—acquired immunodeficiency syndrome	6.03e-05	0.000859	CcSEcCtD
Mirabegron—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.85e-05	0.000832	CcSEcCtD
Mirabegron—Rash—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000832	CcSEcCtD
Mirabegron—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000831	CcSEcCtD
Mirabegron—Headache—Saquinavir—acquired immunodeficiency syndrome	5.81e-05	0.000827	CcSEcCtD
Mirabegron—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000814	CcSEcCtD
Mirabegron—Rash—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000794	CcSEcCtD
Mirabegron—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000793	CcSEcCtD
Mirabegron—Headache—Lamivudine—acquired immunodeficiency syndrome	5.54e-05	0.000788	CcSEcCtD
Mirabegron—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.51e-05	0.000784	CcSEcCtD
Mirabegron—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.25e-05	0.000748	CcSEcCtD
Mirabegron—ABCB1—brain—acquired immunodeficiency syndrome	5.12e-05	0.00519	CbGeAlD
Mirabegron—ABCB1—lymph node—acquired immunodeficiency syndrome	4.94e-05	0.00502	CbGeAlD
